| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |